Chronic learning and memory problems that plague patients with schizophrenia may have a worthy foe in a monoclonal antibody that also holds promise in the fight against cancer and is already used to treat a rare disorder …

Taken from: 

Monoclonal Antibody Shows Promise for Reducing Memory and …